Heart Disease News and Research

Latest Heart Disease News and Research

UH pharmacologist examines age-related oxidative, inflammatory stress

Gaining new insight to managing sodium balance and blood pressure, investigators at the University of Houston (UH) College of Pharmacy believe their work may identify future therapeutic targets to control hypertension.

30 Aug 2012

Fractional flow reserve CT shows potential to non-invasively identify coronary artery disease

A study published in the most recent issue of the Journal of the American Medical Association (JAMA) presented encouraging news regarding physicians' ability to determine blood flow and associated coronary artery disease (CAD) using noninvasive CT scanning technology.

30 Aug 2012

Octogenarians have better survival rates following heart valve surgery

Octogenarians need not shy away from heart valve surgery because of their age; however, those sent home following surgery do better than those discharged to care facilities, according to an observational study published in the September 2012 issue of The Annals of Thoracic Surgery.

30 Aug 2012

Combination of POZEN’s PA32540 and clopidogrel results in greater antiplatelet effects

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, announced the presentation of Phase 1 data, at the European Society of Cardiologists 2012 Congress, from a study of PA32540, a novel coordinated-delivery tablet of enteric-coated (EC) aspirin (325 mg) and immediate-release (IR) omeprazole (40 mg).

30 Aug 2012

SureGene selects PGXL as laboratory provider for STA2R genetic panel

SureGene has chosen PGXL as laboratory provider for its proprietary STA2R genetic panel, which promises to revolutionize the treatment of schizophrenia.

30 Aug 2012

UCSF’s intensive care unit study receives $2.1 million Moore Foundation grant

A multi-center study of intensive care units (ICU) led by UCSF faculty has received a Gordon and Betty Moore Foundation grant of $2.1 million. The study of ICUs, including two at UCSF, aims to better understand the nature of team-based care and patient involvement in ICU settings.

30 Aug 2012

Heart Rhythm Society, ECAS and EHRA develop 2012 expert consensus statement on AF ablation

The 2012 expert consensus statement on catheter and surgical ablation of atrial fibrillation was developed by the Heart Rhythm Society (HRS), the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC), and the European Cardiac Arrhythmia Society (ECAS) and published in their respective journals: Heart Rhythm, EP Europace and the Journal of Interventional Cardiovascular Electrophysiology (JICE).

30 Aug 2012

Elan commences ELND005 Phase 2 study in Bipolar I Disorder

Elan Corporation, plc today announced that it has commenced a Phase 2, placebo-controlled, safety and efficacy study of oral ELND005 as an adjunctive maintenance treatment in patients with Bipolar I Disorder (BPD 1) to delay the time to occurrence of mood episodes.

30 Aug 2012

Carnegie Hill Radiology in New York installs Aquilion PRIME 160 series from Toshiba

Patients with irregular heartbeats (arrhythmia) are difficult to image with CT. Addressing this challenge, Carnegie Hill Radiology in New York installed the Aquilion PRIME 160 series from Toshiba America Medical Systems, Inc., featuring SURECardio Prospective software that automatically adjusts for irregular heartbeats, providing quicker, more accurate exams.

30 Aug 2012

Long-term cardiac impact of Japan quake revealed

The earthquake and tsunami that devastated parts of eastern Japan in 2011 led to a significantly increased weekly occurrence of cardiovascular disease in the months after the event, study findings show.

29 Aug 2012

Tunes and T-shirts for cardiac rehabilitation

Two studies presented at the European Society of Cardiology Congress in Munich, Germany, showed how researchers are developing innovative approaches to help patients get the most out of cardiac rehabilitation.

29 Aug 2012

PROTECT: Still no clear winner in the battle of the stent generations

Three-year rates of stent thrombosis with zotarolimus- and sirolimus-eluting stents are low and comparable, show results of the PROTECT trial.

29 Aug 2012

FAST-MI highlights young women at risk for heart disease

An analysis of four French registries has shown a dramatic drop in ST-segment-elevation myocardial infarction mortality from 1995 to 2010, accompanied by a significant change in patient characteristics.

29 Aug 2012

Mortality risk similar for White vs Black diabetics

Diabetes does not lead to an intrinsically poorer survival in African Americans than it does in White Americans, report US researchers.

29 Aug 2012

DUP may differentiate schizoaffective disorder from BD

Among individuals with a first episode of psychotic mania (FEPM), a longer duration of untreated psychosis may differentiate patients with schizoaffective disorder from those with bipolar I disorder, study results suggest.

29 Aug 2012

Factors linked to occupational disability in BD identified

Occupational disability in patients with bipolar disorder is associated with the presence of axis II disorders, a greater number of previous manic episodes, older age, and not being in a stable relationship, researchers report.

29 Aug 2012

Study finds decline in 30-day mortality of acute myocardial infarction with improved treatment

Improved treatment after acute myocardial infarction and less severe patient profile have reduced 30-day mortality over the past 15 years, according to research presented at ESC Congress 2012.

29 Aug 2012

AstraZeneca’s ticagrelor receives Class I recommendation from ESC

AstraZeneca today announced that ticagrelor, an oral antiplatelet medicine, received a Class I recommendation from the European Society of Cardiology (ESC) in the revised "Guidelines on the Management of Acute Myocardial Infarction in Patients Presenting with Persistent ST-Segment Elevation (STEMI)" guidelines.

29 Aug 2012

Omitting aspirin leads to less bleedings but does not increase risk of stent thrombosis, MI

Lifelong anticoagulation is necessary for the prevention of stroke in patients with rhythm disturbances and with mechanical valves. Patients who have a coronary stent implanted also need the antiplatelet drugs aspirin and clopidogrel to prevent the rare but lethal complication of stent thrombosis.

29 Aug 2012

Study to investigate how breast cancer patients might benefit from exercise

Researchers in Edmonton and Calgary want to recruit 1,500 breast cancer patients over the next decade to find out how exercise and fitness affects cancer survival and recovery.

29 Aug 2012

Heart Disease News and Research

Latest Heart Disease News and Research

UH pharmacologist examines age-related oxidative, inflammatory stress

Fractional flow reserve CT shows potential to non-invasively identify coronary artery disease

Octogenarians have better survival rates following heart valve surgery

Combination of POZEN’s PA32540 and clopidogrel results in greater antiplatelet effects

SureGene selects PGXL as laboratory provider for STA2R genetic panel

UCSF’s intensive care unit study receives $2.1 million Moore Foundation grant

Heart Rhythm Society, ECAS and EHRA develop 2012 expert consensus statement on AF ablation

Elan commences ELND005 Phase 2 study in Bipolar I Disorder

Carnegie Hill Radiology in New York installs Aquilion PRIME 160 series from Toshiba

Long-term cardiac impact of Japan quake revealed

Tunes and T-shirts for cardiac rehabilitation

PROTECT: Still no clear winner in the battle of the stent generations

FAST-MI highlights young women at risk for heart disease

Mortality risk similar for White vs Black diabetics

DUP may differentiate schizoaffective disorder from BD

Factors linked to occupational disability in BD identified

Study finds decline in 30-day mortality of acute myocardial infarction with improved treatment

AstraZeneca’s ticagrelor receives Class I recommendation from ESC

Omitting aspirin leads to less bleedings but does not increase risk of stent thrombosis, MI

Study to investigate how breast cancer patients might benefit from exercise

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in